ACS Nano,
Journal Year:
2024,
Volume and Issue:
18(4), P. 3260 - 3275
Published: Jan. 16, 2024
The
ischemic
stroke
is
a
major
global
health
concern,
with
high
mortality
and
disability
rates.
Unfortunately,
there
dearth
of
effective
clinical
interventions
for
managing
poststroke
neuroinflammation
blood–brain
barrier
(BBB)
disruption
that
are
crucial
the
brain
injury
evolving
neurological
deficits.
By
leveraging
pathological
progression
an
stroke,
we
developed
M2
microglia-targeting
lipid
nanoparticle
(termed
MLNP)
approach
can
selectively
deliver
mRNA
encoding
phenotype-switching
interleukin-10
(mIL-10)
to
brain,
creating
beneficial
feedback
loop
drives
microglial
polarization
toward
protective
phenotypes
augments
homing
mIL-10-loaded
MLNPs
(mIL-10@MLNPs)
regions.
In
transient
middle
cerebral
artery
occlusion
(MCAO)
mouse
model
our
findings
demonstrate
intravenously
injected
mIL-10@MLNPs
induce
IL-10
production
enhance
microglia.
resulting
positive
reinforces
resolution
neuroinflammation,
restores
impaired
BBB,
prevents
neuronal
apoptosis
after
stroke.
Using
permanent
distal
MCAO
neuroprotective
effects
have
been
further
validated
by
attenuation
sensorimotor
cognitive
Furthermore,
mRNA-based
targeted
therapy
has
great
potential
extend
therapeutic
time
window
at
least
up
72
h
poststroke.
This
study
depicts
simple
versatile
LNP
platform
selective
delivery
therapeutics
lesions,
showcasing
promising
addressing
associated
conditions.
Chemical Society Reviews,
Journal Year:
2021,
Volume and Issue:
50(4), P. 2839 - 2891
Published: Jan. 1, 2021
Supramolecular
cancer
nanotheranostics
have
shown
promising
potentials
in
early-stage
diagnosis
and
personal
therapy.
Herein,
we
summarize
the
progress
of
supramolecular
provide
guidance
for
designing
new
targeted
theranostic
agents.
Signal Transduction and Targeted Therapy,
Journal Year:
2023,
Volume and Issue:
8(1)
Published: Aug. 7, 2023
Cancer
remains
a
highly
lethal
disease
in
the
world.
Currently,
either
conventional
cancer
therapies
or
modern
immunotherapies
are
non-tumor-targeted
therapeutic
approaches
that
cannot
accurately
distinguish
malignant
cells
from
healthy
ones,
giving
rise
to
multiple
undesired
side
effects.
Recent
advances
nanotechnology,
accompanied
by
our
growing
understanding
of
biology
and
nano-bio
interactions,
have
led
development
series
nanocarriers,
which
aim
improve
efficacy
while
reducing
off-target
toxicity
encapsulated
anticancer
agents
through
tumor
tissue-,
cell-,
organelle-specific
targeting.
However,
vast
majority
nanocarriers
do
not
possess
hierarchical
targeting
capability,
their
indices
often
compromised
poor
accumulation,
inefficient
cellular
internalization,
inaccurate
subcellular
localization.
This
Review
outlines
current
prospective
strategies
design
organelle-targeted
nanomedicines,
highlights
latest
progress
technologies
can
dynamically
integrate
these
three
different
stages
static
maximize
outcomes.
Finally,
we
briefly
discuss
challenges
future
opportunities
for
clinical
translation
nanomedicines.
Acta Pharmaceutica Sinica B,
Journal Year:
2022,
Volume and Issue:
12(7), P. 3028 - 3048
Published: March 1, 2022
Compared
with
traditional
drug
therapy,
nanomedicines
exhibit
intriguing
biological
features
to
increase
therapeutic
efficiency,
reduce
toxicity
and
achieve
targeting
delivery.
This
review
provides
a
snapshot
of
that
have
been
currently
launched
or
in
the
clinical
trials,
which
manifests
diversified
trend
carrier
types,
applied
indications
mechanisms
action.
From
perspective
indications,
this
article
presents
an
overview
applications
involving
prevention,
diagnosis
treatment
various
diseases,
include
cancer,
infections,
blood
disorders,
cardiovascular
immuno-associated
diseases
nervous
system
etc.
Moreover,
some
considerations
perspectives
research
development
facilitate
their
translations
clinic.
ACS Nano,
Journal Year:
2023,
Volume and Issue:
17(21), P. 20825 - 20849
Published: Nov. 3, 2023
Understanding
the
in
vivo
transport
of
nanoparticles
provides
guidelines
for
designing
nanomedicines
with
higher
efficacy
and
fewer
side
effects.
Among
many
factors,
size
plays
a
key
role
controlling
their
behaviors
due
to
existence
various
physiological
thresholds
within
body
size-dependent
nano-bio
interactions.
Encouraged
by
evolving
discoveries
nanoparticle-size-dependent
biological
effects,
we
believe
that
it
is
necessary
systematically
summarize
size-scaling
laws
nanoparticle
vivo.
In
this
review,
summarized
effect
on
along
journey
body:
begin
administration
via
different
delivery
routes,
followed
targeting
intended
tissues
including
tumors
other
organs,
eventually
clearance
through
liver
or
kidneys.
We
outlined
tools
investigating
as
well.
Finally,
discussed
how
may
leverage
tackle
some
challenges
nanomedicine
translation
also
raised
important
size-related
questions
remain
be
answered
future.
ACS Nano,
Journal Year:
2021,
Volume and Issue:
15(7), P. 11066 - 11086
Published: July 12, 2021
Electrical
stimulation
has
shown
great
promise
in
biomedical
applications,
such
as
regenerative
medicine,
neuromodulation,
and
cancer
treatment.
Yet,
the
use
of
electrical
end
effectors
electrodes
requires
connectors
batteries,
which
dramatically
hamper
translation
technologies
several
scenarios.
Piezoelectric
nanomaterials
can
overcome
limitations
current
procedures
they
be
wirelessly
activated
by
external
energy
sources
ultrasound.
Wireless
mediated
piezoelectric
nanoarchitectures
constitutes
an
innovative
paradigm
enabling
induction
cues
within
body
a
localized,
wireless,
minimally
invasive
fashion.
In
this
review,
we
highlight
fundamental
mechanisms
acoustically
its
applications
area.
adoption
technology
clinical
practice
is
infancy,
open
issues,
properties
measurement,
control
ultrasound
dose
vitro,
modeling
measurement
piezo
effects,
knowledge
on
triggered
bioeffects,
therapy
targeting,
biocompatibility
studies,
delivered
vivo,
must
addressed.
This
article
explores
challenges
proposes
strategies
that
may
guide
future
research
efforts
field
toward
to
scene.
Nano Convergence,
Journal Year:
2021,
Volume and Issue:
8(1)
Published: Nov. 2, 2021
Modern
medicine
has
been
waging
a
war
on
cancer
for
nearly
century
with
no
tangible
end
in
sight.
Cancer
treatments
have
significantly
progressed,
but
the
need
to
increase
specificity
and
decrease
systemic
toxicities
remains.
Early
diagnosis
holds
key
improving
prognostic
outlook
patient
quality
of
life,
diagnostic
tools
are
cusp
technological
revolution.
Nanotechnology
steadily
expanded
into
reaches
chemotherapy,
radiotherapy,
diagnostics,
imaging,
demonstrating
capacity
augment
each
advance
care.
Nanomaterials
provide
an
abundance
versatility,
functionality,
applications
engineer
specifically
targeted
medicine,
accurate
early-detection
devices,
robust
imaging
modalities,
enhanced
radiotherapy
adjuvants.
This
review
provides
insights
current
clinical
pre-clinical
nanotechnological
drug
therapy,
radiation
therapy.
Pharmaceutics,
Journal Year:
2021,
Volume and Issue:
13(7), P. 943 - 943
Published: June 24, 2021
The
use
of
magnetism
in
medicine
has
changed
dramatically
since
its
first
application
by
the
ancient
Greeks
624
BC.
Now,
leveraging
magnetic
nanoparticles,
investigators
have
developed
a
range
modern
applications
that
external
fields
to
manipulate
biological
systems.
Drug
delivery
systems
incorporate
these
particles
can
target
therapeutics
specific
tissues
without
need
for
or
chemical
cues.
Once
precisely
located
within
an
organism,
nanoparticles
be
heated
oscillating
fields,
which
results
localized
inductive
heating
used
thermal
ablation
more
subtle
cellular
manipulation.
Biological
imaging
also
improved
using
as
contrast
agents;
several
types
iron
oxide
are
US
Food
and
Administration
(FDA)-approved
resonance
(MRI)
agents
improve
image
resolution
information
content.
New
modalities,
such
particle
(MPI),
directly
detect
organisms,
allowing
background-free
transport
collection.
"Lab-on-a-chip"
technology
benefits
from
increased
control
provide
over
separation,
leading
separation.
Magnetic
separation
is
becoming
important
next-generation
immunoassays,
both
increase
sensitivity
enable
multiple
analyte
detection.
More
recently,
ability
material
motion
with
been
applied
magnetically
actuated
soft
robotics
designed
biomedical
interventions.
In
this
review
article,
origins
various
areas
introduced,
followed
discussion
current
clinical
applications,
well
emerging
trends
study
materials.